ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,882Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 26

$629K Total Retail Price of All Prescriptions

Rank: 2 out of 26

377 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

25% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 9,600 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 65%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $152 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
HYDROCODONE-ACETAMINOPHEN 734 455 S3 1 6
LEVOTHYROXINE SODIUM 564 472 2 10
OMEPRAZOLE 499 367 3 7
HYDROCHLOROTHIAZIDE 498 427 4 9
SIMVASTATIN 442 317 5 12
LISINOPRIL 393 353 6 16
BENAZEPRIL HCL 387 273 7 19
AMLODIPINE BESYLATE 383 313 8 20
METFORMIN HCL 253 206 9 23
FUROSEMIDE 244 201 10 14
ATENOLOL 218 188 11 27
WARFARIN SODIUM 218 178 11 27
PROAIR HFA 194 120 13 4
ATORVASTATIN CALCIUM 190 169 14 21
POTASSIUM CHLORIDE 180 141 15 31
ZOLPIDEM TARTRATE 179 106 16 17
PRAVASTATIN SODIUM 161 135 17 33
GLIPIZIDE 161 151 17 33
CLONIDINE HCL 160 132 19 35
PREDNISONE 142 95 20 5
ADVAIR DISKUS 135 81 21 2
DIOVAN 131 131 22 30
NAPROXEN 125 101 23 41
JANUVIA 123 93 24 42
SPIRIVA 121 78 25 1
TAMSULOSIN HCL 118 105 26 44
OXYCODONE-ACETAMINOPHEN 118 97 S2 26 44
CEFUROXIME 116 96 28 46
IBUPROFEN 113 78 29 48
METOPROLOL SUCCINATE 110 66 30 49
SERTRALINE HCL 106 74 31 51
SINGULAIR 104 56 32 11
ALENDRONATE SODIUM 99 87 33 53
CARISOPRODOL 95 14 R 34 54
LOSARTAN POTASSIUM 92 79 35 55
AMOX TR-POTASSIUM CLAVULANATE 92 75 35 55
CLOPIDOGREL 89 76 37 57
ENDOCET 88 33 S2 38 58
KLOR-CON 10 87 79 39 59
FLUTICASONE PROPIONATE 86 44 40 8
CRESTOR 83 75 41 60
DIGOXIN 82 82 42 61
LEVOFLOXACIN 79 58 43 39
KETOCONAZOLE 78 47 44 62
RANITIDINE HCL 76 49 45 63
GABAPENTIN 76 59 45 63
TRAZODONE HCL 72 32 47 65
DICLOFENAC SODIUM 72 52 47 65
PLAVIX 71 65 49 67
DILTIAZEM 24HR CD 70 50 50 68
BUMETANIDE 68 44 51 69
AZITHROMYCIN 65 50 52 13
ROPINIROLE HCL 62 28 53 40
NEXIUM 62 41 53 38
FLOVENT HFA 58 26 55 15
LIPITOR 58 47 55 73
PREMARIN 57 47 R 57 74
ISOSORBIDE MONONITRATE ER 56 49 58 75
ALLOPURINOL 55 40 59 25
PROPRANOLOL HCL 55 42 59 77
KLOR-CON M20 53 40 61 79
ACTOS 53 46 61 79
LANTUS 53 30 61 79
OXYBUTYNIN CHLORIDE ER 51 31 64 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.